All individual numbers are from the SEC provided Financial Statement and Notes Data Sets. No guarantee is made for their accuracy. This report only shows the values that are common to a significant number of companies.
ACER THERAPEUTICS INC.: Last Reported 3/31/2020

Business Address

ONE GATEWAY CENTER (300 WASHINGTON ST.)
SUITE 351
NEWTON, MA US 02458

Mailing Address

ONE GATEWAY CENTER (300 WASHINGTON ST.)
SUITE 351
NEWTON, MA US 02458
Phone Number: (844) 902-6100 / State Incorporated: DE / Fiscal Year End 12/31

Balance Sheet

Date 3/31/2020 12/31/2019 9/30/2019 6/30/2019 3/31/2019 12/31/2018 9/30/2018 6/30/2018 3/31/2018 12/31/2017 9/30/2017 6/30/2017 12/31/2016
Cash and Cash Equivalents $7,007,260.00 $12,077,640.00 $16,121,903.00 $23,488,195.00 $31,831,427.00 $41,671,284.00 $46,185,410.00 $8,343,773.00 $12,368,625.00 $15,644,355.00 $8,404,332.00 $2,508,203.00 $1,834,018.00
Accounts Receivable Net Current -- -- -- -- -- -- -- -- -- -- -- -- --
Inventory -- -- -- -- -- -- -- -- -- -- -- -- --
Prepaid Expenses and Other Current Assets $624,520.00 $807,356.00 $972,064.00 $792,230.00 $778,738.00 $1,075,021.00 -- -- -- $881,887.00 -- -- --
Total Current Assets $7,631,780.00 $12,884,996.00 $17,093,967.00 $24,280,425.00 $32,610,165.00 $42,746,305.00 $47,329,504.00 $8,914,946.00 -- $16,526,242.00 -- -- --
Property Plant and Equipement $176,265.00 $193,974.00 $158,796.00 $186,034.00 $210,257.00 $130,867.00 $131,288.00 $67,075.00 -- $62,984.00 -- -- --
Intangible Assets Net -- -- -- -- -- -- -- -- -- -- -- -- --
Goodwill $7,647,267.00 $7,647,267.00 $7,647,267.00 $7,647,267.00 $7,647,267.00 $7,647,267.00 $7,647,267.00 $7,647,267.00 -- $7,647,267.00 -- -- --
Other Assets $566,466.00 $620,674.00 $523,202.00 $568,965.00 $430,251.00 $20,380.00 $34,028.00 $40,528.00 -- $13,648.00 -- -- --
Total Assets $16,140,378.00 $21,465,511.00 $25,541,832.00 $32,801,291.00 $41,016,540.00 $50,663,419.00 $55,260,687.00 $16,788,416.00 -- $24,368,741.00 -- -- --
Accounts Payable $344,800.00 $561,090.00 $29,569.00 $1,538,832.00 $61,167.00 $1,033,829.00 $595,438.00 $861,071.00 -- $95,873.00 -- -- --
Accrued Liabilities $1,171,164.00 $1,944,431.00 $2,154,999.00 $3,171,983.00 $2,759,122.00 $4,546,432.00 $1,559,519.00 $1,870,847.00 -- $1,937,331.00 -- -- --
Total Current Liabilities $2,051,430.00 $3,095,195.00 $2,676,770.00 $5,248,780.00 $3,230,160.00 $5,580,261.00 $2,154,957.00 $2,731,918.00 -- $2,033,204.00 -- -- --
Long Term Debt -- -- -- -- -- -- -- -- -- -- -- -- --
Additional Paid-in Capital $95,287,156.00 $94,619,818.00 $93,958,280.00 $93,394,256.00 $92,586,619.00 $91,914,692.00 $91,440,982.00 $48,426,494.00 -- $47,812,215.00 -- -- --
Accumulated Other Comprehensive Loss -- -- -- -- -- -- -- -- -- -- -- -- --
Accumulated Deficit $-81,199,219.00 $-76,250,512.00 $-71,094,228.00 $-65,842,755.00 $-54,801,248.00 $-46,832,543.00 $-38,336,257.00 $-34,370,746.00 -- $-25,551,652.00 -- -- --
Total Stockholders' Equity $14,088,948.00 $18,370,316.00 $22,865,062.00 $27,552,511.00 $37,786,380.00 $45,083,158.00 $53,105,730.00 $14,056,498.00 $18,565,560.00 $22,335,537.00 -- -- $-10,184,775.00
Controlling Interest in Subsidiaries -- -- -- -- -- -- -- -- -- -- -- -- --
Total Liabilities and Equity $16,140,378.00 $21,465,511.00 $25,541,832.00 $32,801,291.00 $41,016,540.00 $50,663,419.00 $55,260,687.00 $16,788,416.00 -- $24,368,741.00 -- -- --

Statement of Operations

Date 3/31/2020 12/31/2019 9/30/2019 6/30/2019 3/31/2019 12/31/2018 9/30/2018 6/30/2018 3/31/2018 12/31/2017 9/30/2017 6/30/2017 12/31/2016
Total Revenues -- -- -- -- -- -- -- -- -- -- -- -- --
Cost of Revenues -- -- -- -- -- -- -- -- -- -- -- -- --
Gross Profit -- -- -- -- -- -- -- -- -- -- -- -- --
Research and Development $2,322,905.00 $13,851,018.00 $11,021,251.00 $8,192,464.00 $3,946,220.00 $12,452,424.00 $2,377,916.00 $2,688,159.00 $2,073,971.00 $8,725,026.00 $6,948,816.00 $4,891,395.00 --
Selling, General, and Administrative -- -- -- -- -- -- -- -- -- -- -- -- --
Total Operating Expenses $4,971,456.00 $29,897,441.00 $24,705,103.00 $19,342,638.00 $8,176,918.00 $21,713,007.00 $13,014,469.00 $4,916,106.00 $3,991,001.00 $13,948,127.00 $9,741,240.00 $3,014,350.00 --
Loss from Operations $-4,971,456.00 $-29,897,441.00 $-24,705,103.00 $-11,165,720.00 $-8,176,918.00 $-21,713,007.00 $-13,014,469.00 $-8,907,107.00 $-3,991,001.00 $-13,948,127.00 $-3,359,822.00 $-3,014,350.00 --
Loss Before Income Taxes -- -- -- -- -- -- -- -- -- -- -- -- --
Earnings Per Share Basic -- -- -- -- -- -- -- -- -- -- -- -- --
Weighted Average Shares Basic -- -- -- -- -- -- -- -- -- -- -- -- --
Earnings Per Share Diluted -- -- -- -- -- -- -- -- -- -- -- -- --
Weighted Average Shares Diluted -- -- -- -- -- -- -- -- -- -- -- -- --
Common Stock Shares Authorized 150,000,000 150,000,000 150,000,000 150,000,000 150,000,000 150,000,000 150,000,000 150,000,000 -- 150,000,000 -- -- --
Common Stock Shares Outstanding 10,101,034 10,095,176 10,095,176 10,095,176 10,087,363 10,087,363 10,052,988 7,497,433 -- 7,497,433 6,500,000 -- --
Copyright 2020 PursePoor.com